Gladstone in the News
The Gladstone Institutes is gratified to receive media attention from around the globe. Check out the highlights of recent press coverage of Gladstone scientists and research. For other news, please be sure to follow us on Facebook and Twitter.
Three scientists, including Gladstone's Melanie Ott, MD, PhD, have been chosen to receive the 2014 Avant-Garde Award for HIV/AIDS Research from the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health. The three scientists will each receive $500,000 per year for five years to support their research.
A gene variant that scientists already knew to be associated with longer life also seems to make people smarter, and may help offset the effects of normal cognitive decline in old age, according to a team of researchers from the Gladstone Institutes and UCSF.
A hormone associated with longevity also appears to make people's brains work better. The finding in Cell Reports could someday lead to drugs that improve memory and learning, say researchers at the Gladstone Institutes and UCSF.
A potent source of genetic variation in cognitive ability has just been discovered by Gladstone's Lennart Mucke, MD, and UCSF's Dena Dubal, MD, PhD.
Gladstone Investigator Yadong Huang, MD, PhD, sheds light on why women are more likely to develop Alzheimer's than men—which, suggests Huang, may make some future treatments more effective for one gender than the other.
Gladstone's Sheng Ding, PhD, the William K. Bowes, Jr. Distinguished Investigator, uses a revolutionary chemical reprogramming technique to turn skin cells into functional pancreas, liver, and heart cells.
Cardiovascular medicine at Stanford University and the Gladstone Institutes looks to stem cells for answers.
Gladstone Director of Virology and Immunology, Warner C. Greene, MD, PhD, weighs in on Gilead's efforts to develop a functional cure for HIV.
Gladstone HIV expert Warner C. Greene, MD, PhD, weighs in on new research pointing to gene therapy as a way to combat HIV
Researchers at the Gladstone Institutes in California have turned skin cells in mice into insulin producing beta cells, effectively curing the animals of diabetes.